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Sepsis syndrome is a systemic inflammatory
response to infection that ranges from a simple
systemic response to local infection (sepsis) to organ
dysfunction (severe sepsis) to (septic) shock. Sepsis
syndrome is one of the most common causes of
death in patients at University of New Mexico Hospital
(UNMH). However, the mortality rate associated
with sepsis has continuously improved over the last
few years, largely related to the Sepsis Mortality
Improvement Team (SMITe) and its associated
multidisciplinary team. Begun in 2008 as a pilot
program, the SMITe program has grown to become
one of the major focus areas for Quality Improvement
for UNMH and the UNM Health System.
The SMITe team was formed in response to a high
sepsis mortality rate in UNMHospital (UNMH) patients,
and was establishedwith collaboration of Nursing
Unit Directors, Quality Outcomes from UNMH, and
physicians within the Departments of Internal Medicine
and Surgery. Initial goals included early recognition
of patients with sepsis syndrome and initiation of
appropriate evaluation and treatment efforts. These
goals were introduced as a 6 hour Early Goal-Directed
Therapy (EGDT)bundle of care based on recommendations of the international Surviving Sepsis Campaign
but specifically tailored to UNMH systems and the
needs of our patient population. Initial efforts focused
on 4-West and 5-West wards, inpatient units with
large proportions of Internal Medicine Service patients.
However, by mid-2009 the program had expanded
to include inpatient wards throughout the hospital.
Improvements were noted quickly; the number of
sepsis cases identified and documented at UNMH
almost tripled within a year, and observed mortality
and mortality index (observed divided by expected
mortality) in sepsis patients decreased significantly.
While these results were all encouraging, several
important observations were also made over the
first year. The majority of patients with sepsis were
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admitted through the ED, particularly patients
with occult (lactate >4) and frank hemodynamic
septic shock. While these patients represented the
sickest patients with sepsis syndrome, the process
for deciding appropriate admission disposition was
highly variable, poorly coordinated, and extremely
time-consuming. Patients often did not receive the
EGDT bundle in the appropriate time frame, or ended
up admitted to a non-Intensive Care unit (ICU) only
to be transferred to an ICU when they deteriorated,
often with the next 24-48 hours. These results
suggested that the initial improvements in mortality
related to institution of the SMITe program may
have been more related to improved recognition and
treatment of patients with mild-to-moderately severe
sepsis, but mortality of the patients with septic shock
was minimally impacted.
To address these issues, in late 2009 the Departments
of Internal Medicine and Emergency Medicine
collaborated to develop a SMITesubgroup called the
“ED to ICU Workgroup”. The goal of this workgroup
was to develop an early recognition and rapid
treatment process that could be initiated through
the ED. The workgroup included physician, nursing,
and pharmacy leaders as well as frontline personnel
from the Emergency Department and Medical ICU
(MICU). This team focused on a) identification of
highest risk patients for rapid initiation of the severe
sepsis bundled protocol and b) rapid transfer to
the MICU. UNMH provided strong support of the
initiative by ensuring ongoing data collection support,
and by sponsoring the workgroup’s participation in
a nationwide collaborative sponsored by the Institute
for Healthcare Improvement (IHI) addressing the same
issues. The program officially began in November,
2009, and rapid improvement in mortality was noted
within 6 months, going from an initial observed
mortality in patients who met septic shock criteria of
>40% at the start of the project to a mean of 26.7%
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for the first 6 months of 2010. Since then, there has
been a slow, sustained decrease in observed mortality
in patients admitted as part of this program to 21.5%
over the last 6 months of 2013.
It is worth noting that our approach to improving
sepsis mortality at UNMH have been based on classic
QI principles and approaches. The importance of
developing a cohesive, effective multidisciplinary team
cannot be overstated. The ED to ICU Workgroup has
maintained stable leadership and sustained multidisciplinary participation since the program began
in 2008, with membership from UNMH Nursing
units, the Departments of Emergency Medicine and
Internal Medicine, and Pharmacy. The team has
also benefitted from resident and fellow participation at various points in the improvement process,
including: a) improvement of ED to MICU EGDT
transitions through identification of specific signs
and symptoms that should trigger ICU admission, b)
clearly identifying expectations and lines of responsibility for individual bundle elements between ED and
MICU personnel, and c) improving central venous
catheter placement rates to almost 90% during
the last 6 months of 2013. Importantly, there has
been continuous support from departments and
UNMH to maintain ongoing data collection and
analysis. This has allowed projects evaluating new
processes of care, change implementation, and
feedback to involved providers to be data-driven.
Finally, continuous executive leadership support
from Departments within the School of Medicine
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and UNMH have helped reinforce changes in culture
necessary to affect long-term improvements in the
care of these patients.
However, challenges remain related to the care of
patients with sepsis at UNMH. Continuous rotations
of trainees through the ED and MICU present
ongoing challenges in education and feedback.
While we have made significant improvements in
overall sepsis morality, the proportion of UNMH sepsis
patients who develop the disease after admission
(non-present on admission, or non-POA) continue
to have high rates of ICU transfer and mortality.
This subgroup includes patients with significant
co-morbidities, post-operative patients, and patients
with prolonged lengths of stay. These are important
variables measured regularly for public reporting and
inclusion in pay for performance programs such as
Value-Based Purchasing. Earlier this academic year
another initiative was begun to address this patient
subpopulation, and the “non-POA Sepsis Team”
became a member of the SMITe program. In late
2013, this team was accepted into a national collaborative focused on improving mortality in non-POA
sepsis patients. The team will work with teams
from throughout the US to improve processes of
care involved in early recognition and treatment of
non-POA patients on non-ICU wards. We anticipate
that this team will make significant contributions
to improving the care of sepsis patients, and look
forward to resident participation as this initiative
moves forward.
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